Roche’s Evrysdi granted USFDA priority review for treatment of spinal muscular atrophy
Evrysdi is approved in 70 countries and submitted in a further 31 with more than 4,500 patients treated to date
Evrysdi is approved in 70 countries and submitted in a further 31 with more than 4,500 patients treated to date
The oversubscribed round was led by New York-based HOF Capital and welcomed new investors including Headline, East Ventures, MS&AD Ventures, DG Daiwa Ventures, Pioneer Fund, as well as existing investor Insignia Ventures Partners
Astec LifeSciences has reported its financial performance for the quarter ended December 31, 2021
Philips expands remote cardiac monitoring portfolio with patch-based, clinical-grade ECG designed to improve patient recruitment, compliance and retention by reducing need for site visits during clinical trials
Leading brands like Sporlac, Lobun, Oxalo, Pubergen, Nano-leo and Gynogen will now be part of the JBCPL franchise
Optimized for pharma/biopharma to deliver a deeper understanding of cellular function
Studies show significant reduction in pain and improved quality of life for patients treated with spinal cord stimulation compared to medication management alone
The company has been manufacturing masks since the Covid-19 outbreak in 2020
Madhavbaug has a pan-India presence with a vast network of 272 clinics and two hospitals
Al-Futtaim will utilize TytoCare's TytoPro system in outpatient clinics around Dubai, providing patients with enhanced care and better access to specialists
Subscribe To Our Newsletter & Stay Updated